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It is unquestionable that endovascular aneurysm repair
(EVAR) has created a paradigm shift in our ability to manage
patients with ruptured abdominal aortic aneurysms (AAAs). At
Albany Medical Center, shortly after we performed our first rup-
tured EVAR a decade ago in 2002, we realized the potential
benefits of the endovascular technology and techniques for pa-
tients with ruptured AAAs. We also realized the potential limita-
tions that might preclude its widespread utilization, and since then
we have established and published the benefits of a standardized
multidisciplinary approach to rupture EVAR that has resulted in
lowering the overall mortality and morbidity in patients with these
life-threatening emergencies.
Over the past several decades, the overall mortality of open
surgical repair (OSR) for a ruptured AAA has been reported by
most centers to range between 30% and 70% depending on the
local surgeon expertise as well as regionalization of care that
generally has a selection bias against acute hemodynamically un-
stable ruptures that often do not survive to get treatment. Further-
more, over the past decade, a vast majority of 50 publications
(single center, multicenter, National Surgical Quality Improve-
ment Program database, and meta-analysis) in peer reviewed jour-
nals have reported on the benefits of rupture EVAR. The only
studies not indicating rupture EVAR survival advantage are those
b
mn which the rupture EVARmortality ranged from 35% to 50% and
atched that of OSR; a clear indication that surgeons and inter-
entionists should stick to what we do best, albeit rupture EVAR or
SR.
I want to congratulate Dr Saqib and colleagues at the Univer-
ity of Pittsburgh Medical Center for reporting on their 10-year
xperience of ruptured EVAR andOSR. Their experience indicates
hat, with expertise in both emergent EVAR and OSR, the short-
erm mortality can be equally reduced in both groups, albeit the
orbidity of r-EVAR is significantly lower. It would also appear
hat all 37 patients (100%) with ruptured EVAR and only 111 of
41 patients (46%) with ruptured OSR were available for fol-
ow-up and underwent propensity score-based analysis. Although I
pplaud the University of Pittsburgh Medical Center vascular
urgery group to be technically savvy in performing ruptured OSR
nd obtain outcomes that are remarkable, I feel obliged to com-
ent on their inability to include the remaining 54% of patients
ith ruptured OSR has resulted in a cumulative midterm Kaplan-
eier survival analysis that would strongly bias in favor of OSR. It
s likely that a significantly higher percentage of patients that might
e lost to follow-up and were not included in this analysis had died,
any secondary to aneurysm-related complications.
